Prostate Cancer Trial, Recruiting NCT06788886 Sponsor: Mayo Clinic Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06788886
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Study 1:

  • You must be physically healthy enough to do light exercise.
  • You must be able to read and understand English well enough to give consent, follow instructions, and complete any forms or questionnaires.
  • You must have access to a smartphone or tablet.

Study 2:

  • You must be physically healthy enough to do light exercise.
  • Cancer patients with prostate cancer, neuroendocrine tumors, or brain cancer at any stage may be eligible.
  • The study mainly looks at pairs of cancer patients and their caregivers, but individual patients or individual caregivers may also participate.
  • You must be able to read and understand English well enough to give consent, follow instructions, and complete any forms or questionnaires.
  • You must have access to a smartphone or tablet.

Study 3:

  • You must be physically healthy enough to do light exercise.
  • The patient should have multiple sclerosis.
  • You must be able to read and understand English well enough to give consent, follow instructions, and complete any forms or questionnaires.
  • You must have access to a smartphone or tablet.

Who may not be able to join:

Study 1:

  • You cannot have a pacemaker, metallic implants, or anything else that makes you unable to have an MRI scan.
  • You cannot have certain long-term health conditions, including heart disease, high blood pressure, irregular heartbeat, COPD, cystic fibrosis, cancer, diabetes, sleep apnea, aneurysms, epilepsy, Alzheimer's disease, Huntington's disease, essential tremor, or Parkinson's disease.
  • You cannot have certain mental health conditions, including psychosis, suicidal thoughts, bipolar disorder, major depression, or substance use disorders.
  • You cannot be a caregiver for someone with cancer, a neurological disorder, or any of the conditions listed above.
  • You cannot have severe vision or hearing problems, a body mass index (BMI) over 30, or currently be pregnant.
  • You cannot be planning to become pregnant during the study period.

Study 2:

  • You cannot have a pacemaker, metallic implants, or anything else that makes you unable to have an MRI scan.
  • You cannot have chronic lung disease (such as COPD or cystic fibrosis) or an aneurysm, or currently be pregnant.
  • You cannot be planning to become pregnant during the study period.

Study 3:

  • You cannot have a pacemaker, metallic implants, or anything else that makes you unable to have an MRI scan.
  • You cannot have chronic lung disease (such as COPD or cystic fibrosis) or an aneurysm, or currently be pregnant.
  • You cannot be planning to become pregnant during the study period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paul H. Min, PhD, Mayo Clinic in Rochester

Phone: 855-776-0015

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
5 February 2025
Est. completion
18 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in respiratory function correlated with brain activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov